Evaluation of apelin, chemerin, leptin, resistin and vaspin levels in patients with obstructive sleep apnoea syndrome
| dc.authorid | 0000-0002-5338-7355 | |
| dc.authorid | 0000-0002-5180-9649 | |
| dc.authorid | 0000-0001-9982-2714 | |
| dc.contributor.author | Özturk, Eren Kirdar | |
| dc.contributor.author | Yılmaz, Merve Akış | |
| dc.contributor.author | Sarıoglu, Nurhan | |
| dc.contributor.author | Hişmioğulları, Adnan Adil | |
| dc.date.accessioned | 2026-07-01T07:24:35Z | |
| dc.date.issued | 2026 | |
| dc.department | Fakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | |
| dc.description | Yılmaz, Merve Akış (Balikesir Author) | |
| dc.description.abstract | Background: The aim of this study was to investigate serum levels of apelin, chemerin, leptin, resistin, vaspin and advanced glycation end-products (AGEs) relationships with Obstructive Sleep Apnea Syndrome (OSA). Methods: 54 OSA patients and 34 healthy controls participated in this study. The levels of chemerin, leptin, resistin, vaspin and AGEs were determined in the serum by the ELISA method. Results: The chemerin median values were significantly higher (p = 0,012) in the patients group when compared with the control. In contrast, the mean of AGEs in the patient’s group was significantly decreased compared to the control group (p = 0.036). A positive correlation was found between chemerin and apnea-hypopnea index (AHI) (r = 304, p = 0.025) and oxygen desaturation index (ODI) (r = 0.278, p = 0.042). A correlation was also observed among chemerin and haemoglobin (r = 0.228, p = 0.032) and iron (r = 0.339, p = 001). There was a positive correlation between apelin and C-reactive protein (CRP) (r = 0.226, p = 0.034). Leptin was positively correlated with body mass index (BMI), glucose, insulin, HbA1c, haemoglobin and iron. Conclusions: The result of this study demonstrate that chemerin and AGEs are related to OSA physiopathology. These two parameters may help in the diagnosis and progress of sleep apnea. | |
| dc.identifier.doi | 10.1007/s11325-026-03571-9 | |
| dc.identifier.issn | 1520-9512 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 41686282 | |
| dc.identifier.scopus | 2-s2.0-105029958752 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.uri | https://doi.org/10.1007/s11325-026-03571-9 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12462/24187 | |
| dc.identifier.volume | 30 | |
| dc.identifier.wos | WOS:001691401200002 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Springer Science and Business Media Deutschland GmbH | |
| dc.relation.ispartof | Sleep and Breathing | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Apelin | |
| dc.subject | Chemerin | |
| dc.subject | Leptin | |
| dc.subject | Obstructive Sleep Apnea | |
| dc.subject | Resistin | |
| dc.subject | Vaspin | |
| dc.title | Evaluation of apelin, chemerin, leptin, resistin and vaspin levels in patients with obstructive sleep apnoea syndrome | |
| dc.type | Article |












